RFI-675-21-LHSSA-02: Guinea Local Health System Strengthening Activity (LHSSA)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Guinea USAID-Conakry notices from 2021.
Guinea USAID-Conakry offered grants to any type of organization. Applications closed on June 7, 2021.
From the official notice on Grants.gov, last changed May 21, 2021. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeOther
Key dates
| Posted | May 7, 2021 |
|---|---|
| Deadline | June 7, 2021 |
| Archived by Grants.gov | June 8, 2021 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
Dear Interested Parties: The United States Agency for International Development (USAID) in Guinea, hereby issues a Request for Information (RFI) in regard to the Guinea Local Health System Strengthening Activity (LHSSA). The RFI intends to: ● Allow stakeholders and interested organizations to provide information and suggestions on the upcoming activity; and ● Explore innovative approaches to better partner with international and local actors to respond to the host country’s needs and meet the USAID/Guinea’s development objectives.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFI-675-21-LHSSA-02 still open?
No. It closed on June 7, 2021.
Who can apply for Guinea Local Health System Strengthening Activity (LHSSA)?
Guinea USAID-Conakry accepted applications from any type of organization.
What is the deadline for Guinea Local Health System Strengthening Activity (LHSSA)?
Closed June 7, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)